Zimmer Biomet Holdings Inc (ZBH)

Industry Medical Devices
This stock can be held in an Investment ISA and an Investment Account
Sell

$85.00

Buy

$98.96

arrow-down$-0.77 (-0.83%)

Zimmer Biomet Holdings Inc is a medical device company. It designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery under brands like NexGen, Persona, Zimmer, and Polaris.
Prices updated at 02 Jun 2025, 09:00 BST
| Prices minimum 15 mins delay
|
Prices in USD
S&P 500
arrow-down-0.01%
NYSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.

Income statement

Year
chevron-l-regular
chevron-r-regular
20172018201920202021202220232024
7,803m7,933m7,982m6,128m6,827m6,940m7,394m7,679m
5,670m5,661m5,730m4,303m4,867m4,920m5,310m5,487m
1,411m1,147m1,270m705m1,005m1,192m1,451m1,528m
18.0814.4615.9111.5014.7317.1819.6319.90
1,814m-379m1,132m-139m402m231m1,024m904m
1,853m1,059m2,139m1,005m1,645m1,495m2,220m2,251m
Sales, General and administrative3,105m3,379m3,344m2,713m2,843m2,762m2,839m2,930m
Interest expenses325m289m227m212m208m165m201m218m
Provision for income taxes-1,349m108m-226m-96m54m112m42m131m
Operating expenses4,260m4,514m4,460m3,599m3,862m3,728m3,859m3,959m
Income before taxes465m-271m906m-105m499m404m1,067m1,037m
Net income available to common shareholders1,814m-379m1,132m-139m402m231m1,024m904m
8.98-1.865.52-0.671.931.14.914.45
Net interest income-325m-289m-227m-212m-208m-165m-201m-218m
Advertising and promotion--------
Net investment income, net--------
Realised capital gains (losses), net--------
Total benefits, claims and expenses--------
Earnings per share (diluted)8.9-1.865.47-0.671.911.14.884.43
Free cash flow per share8.07477.86325.5795.12426.77685.68914.08756.1099
Book value/share51.578559.886358.648157.187960.806758.587160.850262.1614
Debt equity ratio0.7598540.7464710.5425690.625420.4315480.4286250.390040.428421

Balance sheet

Year
chevron-l-regular
chevron-r-regular
20172018201920202021202220232024
Current assets4,515m4,427m4,724m5,083m4,885m4,427m4,610m4,672m
Current liabilities3,020m2,421m3,442m2,557m3,468m2,358m2,857m2,451m
Total capital20,653m19,685m19,110m19,821m18,124m17,173m17,348m17,810m
Total debt10,143m8,939m8,221m8,127m7,069m5,697m5,768m6,205m
Total equity11,736m11,271m12,388m12,194m12,661m12,020m12,481m12,468m
Total non current liabilities--------
Loans8,918m8,414m6,721m7,627m5,464m5,152m4,868m5,342m
Total assets25,965m24,127m24,639m24,418m23,456m21,066m21,497m21,365m
Total liabilities--------
Cash and cash equivalents524m543m618m802m479m376m416m526m
Common stock203m204m206m208m209m209m206m199m

Cash flow

Year
chevron-l-regular
chevron-r-regular
20172018201920202021202220232024
Cash at beginning of period634m524m543m618m802m479m376m416m
Cash dividends paid-194m-195m-197m-198m-200m-201m-201m-196m
1,426m1,585m1,181m1,087m1,319m1,097m1,204m1,143m
Investments (gains) losses-511m-417m-729m-614m-504m-529m-779m-888m
524m543m618m802m479m376m416m526m
Net income--------
1,582m1,747m1,586m1,205m1,499m1,285m1,582m1,499m
-156m-163m-405m-118m-180m-188m-377m-357m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.